Kanabo Group Plc focuses on the research and development, production, and sale of medical cannabis products to treat CNS disorders. The company intends to offer cannabis-derived products for medical patients; and non-THC products for CBD consumers. It also provides VapePod, a medically certified delivery system for cannabis extracts. The company was founded in 2017 and is based in London, the United Kingdom.